STOCK TITAN

T3 Defense (DFNS) SEC Filings, Sep-Oct 2026

DFNS NASDAQ

Ticker history: NUKK became DFNS (T3 Defense Inc.) on . Earlier news and filings retain their original names and dates. View NUKK history.

T3 Defense Inc. filings document material events for a Nasdaq-listed defense technology holding company, including operating results, acquisitions and dispositions, financing arrangements, debt exchanges, governance matters, capital-structure changes, and exchange-listing compliance. Recent Form 8-K disclosures identify the company's common stock and warrants, emerging growth company status, and securities registered on Nasdaq.

The filing record includes disclosures on note exchanges for common stock, cancellation of indebtedness, private-placement and material-agreement categories, shareholder voting matters, operating and financial results, and a Nasdaq minimum-bid compliance notice. It also documents portfolio-related transactions involving subsidiaries and investments, including Star 26 Capital, Water IO, and Zorronet-related asset disposition activity.

EFFECT
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.61%
Tags
other
-
EFFECT
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.61%
Tags
other
-
Rhea-AI Summary

T3 Defense Inc. (DFNS) may offer up to an aggregate of $250,000,000 of common stock, preferred stock, debt securities, warrants, subscription rights and units, in one or more offerings and in any combination. Specific amounts, prices and terms will be described in prospectus supplements, and the company may not sell securities until the registration statement is effective.

Unless a supplement says otherwise, T3 Defense intends to use any net proceeds for general corporate purposes, including product development and manufacturing, sales and marketing, and working capital. The company says it cannot assure that it will receive proceeds from securities offered under the prospectus. Separately, Series B Preferred Stock automatically converts into common stock or pre-funded warrants on the registration statement’s effective date, whether or not stockholder approval has been obtained.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.64%
Tags
registration
Rhea-AI Summary

T3 Defense Inc. (DFNS) filed Amendment No. 2 to its Form S-1 solely to file certain exhibits. The preliminary prospectus and the balance of Part II are unchanged and omitted from this amendment. The exhibit list includes a certificate correction, a call option agreement, a list of subsidiaries, consents and a filing-fee table.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.61%
Tags
registration
-
Rhea-AI Summary

T3 Defense Inc. filed Amendment No. 2 to its Form S-1 solely to submit certain exhibits identified in Part II. The listed materials include corporate charter amendments, financing instruments, transaction agreements, equity plans and related consents. The preliminary prospectus and the balance of Part II are unchanged and omitted from this amendment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.61%
Tags
registration
-
Rhea-AI Summary

T3 Defense Inc. (DFNS) appointed Shlomo Zakai as chief financial officer, effective October 5, 2026; the Board made the appointment on October 7, 2026. Zakai, 56, has served as CFO of Water IO Ltd., a majority-owned indirect subsidiary of T3 Defense, since June 2026. He previously served as CFO of Duke Robotics Corp. from May 19, 2020, to October 1, 2026, and Save Foods, Inc. from August 2017 to December 2021.

Under a consulting agreement, Zakai will receive $13,000 per month plus VAT. Either party may terminate the agreement on 30 days' prior notice, and T3 Defense may remove him for cause to the extent permitted by applicable law. He will serve at the Board's discretion until a successor is duly appointed and qualified.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.84%
Tags
current report
Rhea-AI Summary

T3 Defense Inc. seeks to register for resale up to 5,100,000 common shares held by selling stockholders, including up to 1,100,000 shares issuable upon conversion of Series B preferred stock and up to 4,000,000 shares issuable upon exercise of common warrants. The holders may sell only after the registration statement becomes effective. T3 will not receive proceeds from resales; it would receive approximately $15 million if all Common Warrants issued in the February 2026 private placement as of the prospectus date are exercised for cash in full, for working capital and general corporate purposes.

First-tranche Series B preferred stock has a $21.375 conversion price, and first-tranche warrants have a $266.25 exercise price; blockers restrict conversion or exercise that would take a holder and affiliates above 9.9% or 9.99% beneficial ownership, respectively. T3 reported 3,250,296 common shares outstanding as of September 30, 2026. At June 30, 2026, it reported approximately $131 million of negative working capital, including $124 million of warrant liabilities that would not require cash to extinguish, and a $19 million stockholders’ deficit. Management concluded that its plans, considered in aggregate, alleviate substantial doubt about its ability to continue as a going concern.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.00%
Tags
registration
-
Rhea-AI Summary

T3 Defense Inc. is registering up to 10,000,000 common shares for resale by Esousa Group Holdings, LLC. T3 will receive no proceeds from Esousa’s resales. Separately, under the purchase agreement, T3 may sell up to $250,000,000 of common stock to Esousa after the registration statement is effective and other agreement conditions are satisfied; T3 decides whether and when to sell.

The purchase price is 97.5% of the lower of the lowest daily VWAP during the 15 trading days through the purchase date or that date’s closing price, and purchases may not exceed 20% of that day’s Nasdaq trading volume. Common shares outstanding were 3,250,296 as of September 30, 2026.

At June 30, 2026, T3 reported approximately $131 million of negative working capital, including $124 million in warrant liabilities that it says require no cash to extinguish, and a $19 million stockholders’ deficit. For the six months ended June 30, 2026, it reported a $7.2 million net operating loss and $9.8 million net cash used in operations. Management said its plans, in aggregate, alleviate substantial doubt about the company’s ability to continue as a going concern.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.00%
Tags
registration
-
Rhea-AI Summary

T3 Defense Inc. (DFNS) may offer and sell, after the registration statement becomes effective, securities in one or more offerings up to an aggregate amount of $125,000,000. The securities may include common stock, preferred stock, debt securities, warrants, subscription rights and units, separately or in combinations. Future prospectus supplements will describe the specific securities, prices, proceeds and terms for each offering. Unless a supplement provides otherwise, net proceeds received are intended for general corporate purposes, including product development and manufacturing, sales and marketing, and working capital; management will have broad discretion over their allocation.

T3 Defense reported 3,250,296 common shares outstanding as of September 29, 2026, plus 29,723 outstanding securities convertible into or exchangeable for common shares. The company also stated that its split-adjusted common stock traded between $3.70 and $91.00 from July 20 through August 25, 2026, and that trading was halted on multiple occasions during July and August due to volatility.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.00%
Tags
registration
Rhea-AI Summary

T3 Defense Inc. (DFNS) has filed a mixed shelf registration allowing it to offer, from time to time, up to $250,000,000 of common stock, preferred stock, debt securities, warrants, subscription rights and units. Specific terms, prices and amounts for each issuance will be set in accompanying prospectus supplements.

The company positions itself as a strategic acquirer and operator of Tier 2 and Tier 3 aerospace and defense suppliers and advanced technology businesses in the U.S., Israel and Europe, with emphasis on dual‑use technologies and AI applications. DFNS is both a smaller reporting company and an emerging growth company, which permits reduced disclosure and audit requirements.

The risk discussion highlights very high stock volatility and a 1‑for‑125 reverse stock split effective July 20, 2026, after which the share price traded between $3.70 and $91.00 with widely varying volumes and multiple trading halts. The prospectus also details significant potential dilution from future equity offerings and from outstanding Series B Preferred Stock, which is highly convertible and carries 10,000 votes per share, subject to a 9.9% beneficial‑ownership blocker.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.25%
Tags
registration

FAQ

How many T3 Defense (DFNS) SEC filings are available on StockTitan?

StockTitan tracks 69 SEC filings for T3 Defense (DFNS), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for T3 Defense (DFNS)?

The most recent SEC filing for T3 Defense (DFNS) was filed on November 16, 2026.